Latest Breaking News On - Colitis congress - Page 5 : comparemela.com

AI boom makes inroads in GI: AI may improve diagnosis, experts still urge caution

'Evidence supports' de-escalating combination therapy in patients with IBD after 1 year

DENVER — Providers should consider de-escalating combination therapy with immunomodulators to monotherapy after 1 year in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress. “We know that combination therapy is one of our most, if not the most, effective therapies: not the combination of biologics, but the combination of the

Crohns Disease Treatment Market Growth Insights | 2030 Industry Value Touches US$ 15.17 Billion in Terms of Revenue | Pfizer Inc., Eli Lilly and Company, Novartis AG, Sanofi |

Chronic inflammation of the digestive tract is referred to as inflammatory bowel disease (IBD), of which Crohn's disease is a type. The small intestine

Meat-Heavy Diets May Lead to Ulcerative Colitis Flares

Patients with ulcerative colitis and meat-heavy diets had twice as many flares as those who ate less meat.

IBD care updates of 2023 (so far): Promising strategies to improve patient quality of life

Two of the most important goals in the treatment of patients with inflammatory bowel disease are to improve patient quality of life and increases the odds of remission.